XELLERA THERAPUTICS
Live / Registered — Registered (as of 01 Dec 2020)
What this means for you
Registered since 01 Dec 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 01 Dec 2026, and its filing window is open now).
Record
- Serial number
- 88977235
- Registration number
- 6211225
- Mark type
- Stylized text
- Filed
- 27 May 2019
- Published for opposition
- 28 Apr 2020
- Registered
- 01 Dec 2020
- Next maintenance filing
- §8 declaration of use, due by 01 Dec 2026 (grace period to 01 Jun 2027)
- Attorney of record
- Kevin O'Keefe
Goods and services
- Class 009 — Scientific and electric apparatus: bioreactor for cell culturing; Bioreactors for laboratory use; Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; Computer-controlled electronic apparatus for electrophysiological measurement and testing of cells
- Class 010 — Medical apparatus: Apparatus for the regeneration of stem cells for medical purposes; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical apparatus and instruments for treating cardiovascular disease; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical diagnostic apparatus for testing blood antigens and antibodies
- Class 040 — Treatment of materials: Biomanufacturing for others, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process; Contract manufacturing in the field of biotechnology; Cryogenic preservation; Cryopreservation of human tissue; Custom manufacture of biopharmaceuticals by pharmaceutical compounders; Manufacture of pharmaceuticals to order and/or specification of others; Manufacturing services for others in the field of stem cells; Providing technical information in the field of pharmaceutical manufacturing
- Class 042 — Scientific and technological services: Biological research; Biomedical research services; Biotechnology research; Chemical research; Conducting clinical trials for others; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug discovery services; Industrial research in the field of regenerative and reparative therapies; Medical laboratory services; Medical research; Pharmaceutical drug development services; Pharmaceutical research services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products for others; Research and development of vaccines and medicines; Scientific research; Scientific research and development; Scientific research in the field of gene therapy; Stem cell research services; Technology research in the field of regenerative and reparative therapies
- Class 044 — Medical, beauty and agricultural services: Blood bank services; Health care services, namely, regenerative and reparative therapies; Human tissue bank services; Medical care; Medical services; Medical services in the field of regenerative and reparative therapies; Medical testing for diagnostic or treatment purposes in the field of regenerative and reparative therapies; Organ and tissue bank services; Stem cell therapy services
Owner
- XELLERA THERAPEUTICS LIMITED, HUNG HOM, KLN, HK
- XELLERA THERAPEUTICS LIMITED, HUNG HOM, KLN, HK
- XELLERA THERAPEUTICS LIMITED, HUNG HOM, KLN, HK
Prosecution history
- 01 Dec 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 08 Dec 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Dec 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Dec 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 01 Dec 2020 — REGISTERED-PRINCIPAL REGISTER
- 29 Oct 2020 — REVIEW OF CORRESPONDENCE COMPLETE
- 29 Oct 2020 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 07 Oct 2020 — NOTICE OF ALLOWANCE CANCELLED
- 07 Oct 2020 — TEAS DELETE 1(B) BASIS RECEIVED
- 23 Jun 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Apr 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Apr 2020 — PUBLISHED FOR OPPOSITION
- 08 Apr 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Mar 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Mar 2020 — DIVISIONAL PROCESSING COMPLETE